China conditionally approves recombinant protein COVID-19 vaccine

02.03.2022 [18:28]
Print
A⁺ A^-

Baku, March 2, AZERTAC

China conditionally approved the registration application of a self-developed recombinant protein subunit vaccine against COVID-19, the National Medical Products Administration said Wednesday, according to Xinhua.

The vaccine, developed by Anhui Zhifei Longcom Biopharmaceutical Co., Ltd., was allowed to enter the market on a conditional basis, said the administration.

It marked the first approved COVID-19 recombinant protein subunit vaccine in China.

China conditionally approves recombinant protein COVID-19 vaccine

FEEDBACK

Other news in this section